Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts

Biochemical Pharmacology

Volumn 38, Issue 11, 1989, Pages 1727-1736

  Horton, Julie K ^a   Thimmaiah, Kuntebommanahalli N ^b   Houghton, Janet A ^a   Horowitz, Marc E ^a,c   Houghton, peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MYSORE   (India)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; VERAPAMIL; VINCRISTINE; VINCRISTINE SULFATE;

ANIMAL EXPERIMENT; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RHABDOMYOSARCOMA; THYMECTOMY; TUMOR XENOGRAFT;

ANIMAL; BIOTRANSFORMATION; DRUG RESISTANCE; HUMAN; MICE; NEOPLASM TRANSPLANTATION; RHABDOMYOSARCOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION; VERAPAMIL; VINCRISTINE;

EID: 0024339994     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(89)90405-X     Document Type: Article

References (50)

1. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross resistance, radioautographic and cytogenetic studies
2. Reduced permeability in CHO cells as a mechanism of resistance to colchicine
3. In vivo characteristics of resistance and cross resistance of an adriamycin-resistant subline of P388 leukemia
4. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts
5. Multiple drug resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin or vinblastine show changes in expression of specific proteins
6. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562
7. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
8. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
9. Detection of P glycoprotein in multi-resistant cell lines by monoclonal antibodies
10. Cell surface Pglycoprotein associated with multidrug resistance in mammalian cell lines
11. The mdr I gene, responsible for multidrug-resistance, codes for Pglycoprotein
12. Isolation and expression of a complementary DNA that confers multidrug resistance
13. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins
14. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
15. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
16. Reversal of adriamycin resistance by verapamil in human ovarian cancer
17. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs
18. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluperazine
19. Overcoming drug resistance in cancer cells with synthetic isoprenoids
20. Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine and chlorpromazine
21. Lysosomotroplc agents reverse multiple drug resistance in human cancer cells
22. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro
23. Membrane modification can reverse a mode of anthracycline resistance
24. Mode of action of calcium antagonists which alter anthracycline resistance
25. Certain calcium channel blockers bind specifically to multidrugresistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein
26. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-gly-coprotein by a vinblastine analog
27. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
28. Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma
29. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug
30. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin- resistant and -sensitive leukemia in vitro and in vivo
31. Occurrence of a multidrug-resistant phenotype in human lung xenografts
32. Phase I study of vinblastine and verapamil given by concurrent i.v. infusion
33. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
34. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered β-tubulins
35. Expression of the multidrug resistance gene (mdr 1) in human xenografts sensitive or resistant to natural products
36. On the mechanism of cytotoxicty of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice
37. Growth and characterization of childhood rhabdomyosarcomas as xenografts
38. Chromatographie analysis of Vinca alkaloids in human neoplastic and host (mouse) tissues after injection in vivo or after incubation in vitro
39. Scheduling of vincristine: Drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration
40. Determinants of intrinsic sensitivity to vinca alkaloids in xenografts of pediatrie rhabdomyosarcomas
41. Stability of vincristine complexes in cytosols derived from xenografts of human rhabdomyosarcoma and normal tissues of the mouse
42. Expression of a multidrugresistant gene in human tumors and tissues
43. Identification of a multidrug resistance associated antigen (P-glycoprotein) in normal human tissues
44. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
45. Tissue distribution of P-glycoprotein encoded by a multidrug-resistantgene as revealed by a monoclonal antibody, MRK16
46. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus
47. Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats
48. Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts
49. Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil
50. Verapamil sensitizes normal and neoplastic rodent intestinal tissues to the stathmokinetic effect of vincristine in vivo